Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Alcoholic Hepatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Baylor St. Luke Medical Center, Houston, Texas, United States
Contact: Study coordinator (Prasun K. Jalal, MD) · Jalal@bcm.edu · 832-355-1424

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Hepatitis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Mobile, United States

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

Alcoholic Hepatitis

Abroad (travel likely)RecruitingPHASE3

Lille, France

HA35 Moderate Alcoholic Hepatitis (AH) Study

Alcoholic Hepatitis

Abroad (travel likely)RecruitingEARLY_PHASE1

Cleveland, United States

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Alcohol Use Disorder · Alcoholic Hepatitis

Abroad (travel likely)Recruiting

Baltimore, United States